BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guo S, Bai X, Shi S, Li S, Liu X, An H, Kang X. Multi-target tracheloside and doxorubicin combined treatment of lung adenocarcinoma. Biomed Pharmacother 2022;153:113392. [PMID: 35834992 DOI: 10.1016/j.biopha.2022.113392] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Yang T, Zhang Z, Zhang J, Li Y, Li W, Liang H, Yang F. Developing a Gallium(III) Agent Based on the Properties of the Tumor Microenvironment and Lactoferrin: Achieving Two-Agent Co-delivery and Multi-targeted Combination Therapy of Cancer. J Med Chem 2023;66:793-803. [PMID: 36544423 DOI: 10.1021/acs.jmedchem.2c01684] [Reference Citation Analysis]
2 Bai X, Cheng Y, Wan H, Li S, Kang X, Guo S. Natural Compound Allicin Containing Thiosulfinate Moieties as Transmembrane Protein 16A (TMEM16A) Ion Channel Inhibitor for Food Adjuvant Therapy of Lung Cancer. J Agric Food Chem 2023;71:535-45. [PMID: 36574498 DOI: 10.1021/acs.jafc.2c06723] [Reference Citation Analysis]
3 Shi S, Bai X, Ji Q, Wan H, An H, Kang X, Guo S. Molecular mechanism of ion channel protein TMEM16A regulated by natural product of narirutin for lung cancer adjuvant treatment. Int J Biol Macromol 2022;223:1145-57. [PMID: 36400205 DOI: 10.1016/j.ijbiomac.2022.11.123] [Reference Citation Analysis]